精准医学的进步:针对2型糖尿病患者量身定制的甲福林治疗的多奥米克方法
Najeha Rizwana Anwardeen1, Khaled Naja1, Mohamed A Elrayess1,2
1Biomedical Research Center, Qatar University, Doha, Qatar.
Frontiers in pharmacology
|December 13, 2024
概括
甲胺是一种关键的2型糖尿病药物,但患者的反应各不相同. 这篇评论探讨了遗传学,新陈代谢和肠道细菌如何影响甲福明的有效性,旨在提供个性化的糖尿病护理.
科学领域:
- 内分泌学和新陈代谢学
- 药物基因组学 药物基因组学
- 微生物组研究 微生物组研究
背景情况:
- 甲胺是2型糖尿病的主要治疗方法,有效降低血糖.
- 有相当数量的患者在使用甲福林时无法达到血糖目标.
- 患者对甲福明的反应的变化需要进一步的研究,而不仅仅是遗传学.
研究的目的:
- 探索影响美特福林反应的分子特征.
- 调查遗传学,代谢学和肠道微生物群之间的相互作用对美特福林的疗效.
- 识别用于个性化糖尿病管理的甲胺-微生物群相互作用的知识差距.
主要方法:
- 对最近关于甲福明反应的研究的文献综述.
- 对遗传,代谢和微生物组数据的分析.
- 探索分子特征及其对药物疗效的影响.
主要成果:
- 遗传因素解释了大约三分之一的甲福林反应变化.
- 代谢成分和肠道微生物组合显示出对药物疗效的潜在影响.
- 主体因素和微生物群落之间的复杂相互作用塑造了个体的反应.
结论:
- 了解个体分子形状对于优化甲福林治疗至关重要.
- 个性化糖尿病管理策略可以改善治疗结果.
- 需要对甲胺-肠道微生物群轴进行进一步的研究,以推进治疗方法.
相关概念视频
Oral Hypoglycemic Agents: Biguanides and Glitazones
172
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
172
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Diabetes: Management and Pharmacotherapy
235
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
235
Diabetes Mellitus: Type 2 and Gestational
2.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.2K
Diabetes Mellitus: Overview and Type I Subtype
2.4K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.4K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K


